PAXMEDICA (PXMD) Financials

PAXMEDICA INC (PXMD) has a return on equity of -540.3% for fiscal year 2023, measuring how efficiently the company generates profit from shareholder equity.

PAXMEDICA INC (PXMD) recorded an outflow of $10.8M in operating cash flow during fiscal year 2023, representing cash used by core business activities.

PAXMEDICA INC (PXMD) had $5.7M in total assets as of fiscal year 2023, including both current and long-term assets.

PAXMEDICA INC (PXMD) invested $3.9M in research and development during fiscal year 2023.

PAXMEDICA INC (PXMD) had 7M shares outstanding as of fiscal year 2023.

PAXMEDICA INC (PXMD) had a current ratio of 3.16 as of fiscal year 2023, which is generally considered healthy.

PAXMEDICA INC (PXMD) had a liabilities-to-equity ratio of 0.68 as of fiscal year 2023, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2023, because the filing data we hold for that year carries no long-term debt figure.

PAXMEDICA INC (PXMD) had a return on assets of -322.0% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2023, PAXMEDICA INC (PXMD) held $4.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $10.8M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

PAXMEDICA INC (PXMD) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

PAXMEDICA INC (PXMD) reported a net loss of $18.3M while operations used $10.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

PAXMEDICA INC (PXMD) reported an operating loss of $16.1M against $9K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.